|
Real-world multi-target stool DNA longitudinal adherence for colorectal cancer re-screening in a large, national population. |
|
|
Employment - Exact Sciences; Exact Sciences |
Stock and Other Ownership Interests - Exact Sciences |
Research Funding - Exact Sciences |
Travel, Accommodations, Expenses - Exact Sciences |
|
|
(OPTIONAL) Uncompensated Relationships - Exact Sciences |
|
|
Consulting or Advisory Role - Exact Sciences (Inst) |
|
|
Employment - Exact Sciences |
Stock and Other Ownership Interests - Exact Sciences |
Travel, Accommodations, Expenses - Exact Sciences |
|
|
Employment - Exact Sciences |
Stock and Other Ownership Interests - Exact Sciences |
|
|
Consulting or Advisory Role - Exact Sciences (Inst) |
Research Funding - Exact Sciences (Inst) |
Patents, Royalties, Other Intellectual Property - Exact Sciences (Inst) |
Travel, Accommodations, Expenses - Exact Sciences (Inst) |
|
|
No Relationships to Disclose |
|
|
Employment - Exact Sciences |
Stock and Other Ownership Interests - Exact Sciences |
|
|
Employment - Exact Sciences |
Leadership - Exact Sciences (Inst) |
Stock and Other Ownership Interests - Exact Sciences |
Consulting or Advisory Role - Exact Sciences (Inst) |
Research Funding - Exact Sciences (Inst); Ironwood Pharmaceuticals (Inst); Thorne Research (Inst) |
Patents, Royalties, Other Intellectual Property - Prior to becoming an Exact Sciences employee in July 2022, Dr. Limburg served as Chief Medical Officer for Screening at Exact Sciences through a contracted services agreement with Mayo Clinic. Dr. Limburg and Mayo Clinic had contractual rights to receive |